中国疗养医学
中國療養醫學
중국요양의학
CHINESE JOURNAL OF CONVALESCENT MEDICINE
2015年
7期
734-736
,共3页
贾长龙%范占东%李明月%白彬彬%成伟丽
賈長龍%範佔東%李明月%白彬彬%成偉麗
가장룡%범점동%리명월%백빈빈%성위려
慢性阻塞性肺疾病%糖尿病%糖皮质激素%并发症%肺功能
慢性阻塞性肺疾病%糖尿病%糖皮質激素%併髮癥%肺功能
만성조새성폐질병%당뇨병%당피질격소%병발증%폐공능
Chronic obstructive pulm onary disease(COPD)%Diabetes%Glucocorticoid%Com plication%Lung function
目的:分析治疗慢性阻塞性肺疾病( COPD )合并糖尿病患者最佳的糖皮质激素应用剂量。方法回顾性分析北京军区北戴河疗养院2004-01—2012-01收治的600例COPD合并糖尿病患者的临床资料。将患者分为3组,即低剂量、中等剂量和高剂量糖皮质激素治疗组。观察患者接受治疗后肺功能及并发症情况。结果3组患者在治疗后12个月监测肺功能,VC、FVC、FEV1、FEV1/FVC四项功能指标组间差异均无统计学意义(P>0.05);然而治疗后随访期间,糖皮质激素剂量依赖性糖尿病相关并发症累计发生次数在高剂量组明显高于中等剂量组及低剂量组(P<0.05)。结论中、低剂量糖皮质激素治疗COPD合并糖尿病的患者既能达到治疗效果,同时能明显减少患者糖尿病相关并发症的发生率。
目的:分析治療慢性阻塞性肺疾病( COPD )閤併糖尿病患者最佳的糖皮質激素應用劑量。方法迴顧性分析北京軍區北戴河療養院2004-01—2012-01收治的600例COPD閤併糖尿病患者的臨床資料。將患者分為3組,即低劑量、中等劑量和高劑量糖皮質激素治療組。觀察患者接受治療後肺功能及併髮癥情況。結果3組患者在治療後12箇月鑑測肺功能,VC、FVC、FEV1、FEV1/FVC四項功能指標組間差異均無統計學意義(P>0.05);然而治療後隨訪期間,糖皮質激素劑量依賴性糖尿病相關併髮癥纍計髮生次數在高劑量組明顯高于中等劑量組及低劑量組(P<0.05)。結論中、低劑量糖皮質激素治療COPD閤併糖尿病的患者既能達到治療效果,同時能明顯減少患者糖尿病相關併髮癥的髮生率。
목적:분석치료만성조새성폐질병( COPD )합병당뇨병환자최가적당피질격소응용제량。방법회고성분석북경군구북대하요양원2004-01—2012-01수치적600례COPD합병당뇨병환자적림상자료。장환자분위3조,즉저제량、중등제량화고제량당피질격소치료조。관찰환자접수치료후폐공능급병발증정황。결과3조환자재치료후12개월감측폐공능,VC、FVC、FEV1、FEV1/FVC사항공능지표조간차이균무통계학의의(P>0.05);연이치료후수방기간,당피질격소제량의뢰성당뇨병상관병발증루계발생차수재고제량조명현고우중등제량조급저제량조(P<0.05)。결론중、저제량당피질격소치료COPD합병당뇨병적환자기능체도치료효과,동시능명현감소환자당뇨병상관병발증적발생솔。
Objective To discuss the best dosage of glucocorticoid application to treat severe COPD sufferers com-plicated with diabetes.Methods The clinical data of 600 COPD sufferers com plicated with diabetes adm itted to Bei-daihe Sanatorium of Beijing Military R egion from January 2004 to January 2012 were retrospectively analyzed.A ll suf-ferers were divided into three groups according to the dosage of glucocorticoid:low-dosage group ,m oderate-dosage group and high-dosage group .The lung functions and com plications of the sufferers after treatm ent were evaluated . Results A fter 12 m onths treatm ent,the lung functions of the three groups were m onitored ,and the differences of four functional param eters including VC ,FVC ,FEV1,and FEV1/FVC had no statistical significance(P>0.05).H owever,dur-ing the follow-up visit after treatm ent,it was found that the glucocorticoid dose-dependent diabetes com plications rate in the high-dosage group was clearly higher than the other two groups significantly (P<0 .05 ).Conclusion The treat-m ent effect with low-doage and m oderate-dosage of glucocorticoid to treat COPD sufferers com plicated with diabetes was satisfactory,and it can clearly reduce the diabetes-related com plication rate.